|1.||Ramanujam, Nirmala: 3 articles (01/2015 - 02/2011)|
|2.||Frees, Amy E: 2 articles (01/2015 - 01/2013)|
|3.||Rajaram, Narasimhan: 2 articles (01/2015 - 01/2013)|
|4.||Gillenwater, Ann: 2 articles (12/2013 - 06/2009)|
|5.||Richards-Kortum, Rebecca: 2 articles (12/2013 - 06/2009)|
|6.||Mulvey, Christine S: 1 article (01/2015)|
|7.||Reesor, Andrew F: 1 article (01/2015)|
|8.||Guo, Lili: 1 article (12/2014)|
|9.||Yu, Mei: 1 article (12/2014)|
|10.||Shi, Mingyi: 1 article (12/2014)|
01/01/2013 - "Our results demonstrate that 2-NBDG uptake in tumors is influenced by the rates of delivery and clearance of the tracer. "
01/01/2013 - "In the 4T07 tumors, 2-NBDG uptake increased with increasing rates of delivery at low rates of clearance. "
01/01/2013 - "2-NBDG uptake in the 4T1 tumors was lowest when rates of delivery and clearance were lowest, indicating perfusion-limited uptake in poorly oxygenated tumor regions. "
02/01/2011 - "A subset of cancer cells was treated with anticancer and endocrine therapies, and 2-NBDG fluorescence changes were measured. "
06/01/2009 - "In contrast, high-grade dysplasia and cancers show uptake of 2-NBDG in neoplastic cells throughout the lesion. "
|3.||Breast Neoplasms (Breast Cancer)
06/01/2011 - "Multi-spectral images of 14 breast cancer specimens acquired before and after incubation with 2-NBDG demonstrated increased fluorescent signal in all of the malignant tissue due to increased 2-NBDG consumption. "
02/01/2011 - "LND directly inhibits HK and significantly reduced 2-NBDG fluorescence in a subset of two breast cancer cell lines. "
02/01/2011 - "GLUT 1 expression and 2-NBDG uptake was ubiquitous among all breast cancer lines. "
02/01/2011 - "Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines."
07/01/2010 - "[Uptake of 2-NBDG by human breast cancer cells in vitro]."
11/01/2009 - "2-NBDG uptake in the brain of a mouse experiencing a generalized seizure is measured, as well as in subcutaneously implanted tumors in mice during fed and fasting states. "
01/15/2012 - "The initial uptake rate of 2-NBDG at the injection site of 4-aminopyridine significantly exceeded that of the control injection site, which indicated local hypermetabolism induced by seizures. "
|5.||Ganglion Cysts (Ganglion)
|3.||Facilitative Glucose Transport Proteins (Glucose Transporter)
|5.||Glucose Transporter Type 4
|6.||Vesicle-Associated Membrane Protein 2 (VAMP2)
|7.||4-Aminopyridine (4 Aminopyridine)
|8.||Vitamin A (Retinol)
|9.||Messenger RNA (mRNA)
|1.||Heterologous Transplantation (Xenotransplantation)